BMJ7d
Forecasting cardiovascular disease risk and burden in China from 2020 to 2030: a simulation study based on a nationwide cohort
1 General Office of the Institute of Clinical Medicine, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China 2 National Clinical ...
BMJ9d
Right ventricle’s road to recovery: remodelling after chronic thromboembolic pulmonary hypertension intervention
Right heart failure is the most common cause of mortality in patients with pulmonary arterial hypertension.1 This includes chronic thromboembolic pulmonary hypertension (CTEPH), which through ...
BMJ13d
Breaking new ground in treatment of coronary calcium
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be ...
BMJ19h
Use of intravenous magnesium to treat acute onset atrial fibrillation: a meta-analysis
Dr K M Ho, Intensive Care Unit, Royal Perth Hospital, Perth, WA 6000, Australia; kwok.ho{at}health.wa.gov.au Objectives: To assess the effects of intravenous magnesium on converting acute onset atrial ...
BMJ22h
Cardiovascular genetics: the role of genetic testing in diagnosis and management of patients with hypertrophic cardiomyopathy
Correspondence to Dr Carolyn Y Ho, Cardiovascular Division, Brigham and Women's Hospital, Boston, MA 02115, USA; cho{at}bwh.harvard.edu Genetic testing in hypertrophic cardiomyopathy (HCM) is a ...
BMJ6d
A single serum glucose measurement predicts adverse outcomes across the whole range of acute coronary syndromes
Objectives: To analyse the relation between serum glucose concentration and hospital outcome across the whole spectrum of acute coronary syndromes. Methods: This was a prospective cohort study of 2127 ...
BMJ8d
Impact of heart disease on maternal, fetal and neonatal outcomes in a low-resource setting
Background The burden of pre-existing cardiovascular disease and the contribution to adverse pregnancy outcomes are not robustly quantified, particularly in low-income countries. We aimed to determine ...
BMJ3d
Stimulation of collateral artery growth: travelling further down the road to clinical application
Dr S H Schirmer, Department of Cardiology, Academic Medical Centre, Meibergdreef 9, 1105 AZ Amsterdam, The Netherlands; Stephan.schirmer{at}uks.eu Collateral artery growth is a potent natural defence ...
BMJ2d
14 Time to TAVI: streamlining the outpatient pathway to treatment
Introduction Transcatheter Aortic Valve Implantation (TAVI) is an established treatment option for severe aortic stenosis (AS), with over 5000 procedures performed in the UK in 2019. Given the high ...
BMJ5d
Pericardial diseases in patients with hypothyroidism
Correspondence to Dr. Allan L Klein, Center for the Diagnosis and Treatment of Pericardial Diseases, Heart and Vascular Institute, Cleveland Clinic, Cleveland, Ohio, USA ; kleina{at}ccf.org ...
BMJ3d
Rationale and design of a randomised trial of intravenous iron in patients with heart failure
Correspondence to Dr Ian Ford, University of Glasgow Robertson Centre for Biostatistics, Glasgow G12 8QQ, UK; ian.ford{at}glasgow.ac.uk Methods IRONMAN is a prospective, randomised, open-label, ...
BMJ2d
Chocolate consumption and risk of cardiovascular diseases: a meta-analysis of prospective studies
1 The Affiliated Luohu Hospital, Shenzhen University Health Science Center, Shenzhen, China Objective Studies investigating the impact of chocolate consumption on cardiovascular disease (CVD) have ...